Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy

Li, HX; Wang, CY; Wang, ZQ; Hu, YB; Zhang, GW; Zhang, MN; Zheng, XX; Zhang, XJ; Yang, JB; Ma, ZY; Wang, HJ

Wang, HJ (reprint author), Zhengzhou Univ, Dept Resp Med, Affiliated Canc Hosp, 127 Dongming Rd, Zhengzhou, Henan, Peoples R China.

LUNG CANCER, 2019; 130 (): 42

Abstract

Purpose: This study aims to understand the effects and long-term survival of 1st generation epithelial growth factor receptor tyrosine kinase inhibito......

Full Text Link